Cyronix Aurora Protocol

Cryonix Aurora Protocol brings together two widely studied peptides into a single dual-compound configuration. This bundle includes Retatrutide and Melanotan II (MT2), two compounds that interact with different biological pathways and are frequently explored within modern peptide research.

Compound Configuration Notice

Each Cryonix bundle contains individual, separately prepared vials of each compound. The peptides supplied in this configuration are not blended, combined, or pre-mixed in any formulation. All compounds remain independent to preserve their original research form.

Included Compounds

Cryonix Retatrutide

Retatrutide is a triple receptor agonist peptide currently being investigated in metabolic research. It interacts with GLP-1, GIP, and glucagon receptor pathways and has become a major focus in emerging peptide science.

Cryonix Melanotan II

Melanotan II (MT2) is a synthetic analogue of alpha-MSH that interacts with melanocortin receptors. It has been widely studied in peptide research relating to pigmentation pathways and melanocortin signalling systems.

Bundle Includes

• 1 × 10mg Retatrutide vial

• 1 × 10mg Melanotan II vial or 20mg spray

• Research accessories including bacteriostatic water and sterile preparation supplies

• Informational reference card
  

More Information:

For further details or assistance, please contact us via Telegram.

Our team is available to provide general product information within compliant guidelines.

Disclaimer:

By using this website and completing a purchase, you acknowledge and agree to all Terms & Conditions, Policies, and the full Compliance & Legal Disclaimer. All products are supplied strictly for research and educational use only, and customers accept full responsibility for their own actions, usage, and outcomes.